Drawbridge Health

Drawbridge Health is a private, pre-revenue diagnostics company pioneering a novel platform for simplified blood collection. Its flagship product, the OneDraw® Blood Collection System, is designed to enable patients or healthcare professionals to collect a small, high-quality blood sample easily at home or in point-of-care settings, which can then be mailed to a lab for analysis. This approach addresses key challenges in traditional venous blood draws, including patient discomfort, logistical barriers, and the need for trained phlebotomists. The company's strategy targets the growing demand for decentralized and digital health solutions, particularly in chronic disease management and clinical trials.

The OneDraw® platform is an integrated, single-use blood collection device for capillary blood from a fingerstick. It features a retractable lancet, a microfluidic channel for precise volume collection, and a stabilizer that preserves the sample at ambient temperature for mailing to a central lab for analysis using standard equipment.

Drawbridge competes in the remote blood collection space against startups like Tasso (with its Tasso+ device) and Seventh Sense Biosystems, as well as initiatives from large diagnostic service providers like Labcorp (with its Labcorp At-Home kit) and Quest Diagnostics. Competition is based on device simplicity, sample quality, volume, lab compatibility, and menu of available tests.